James Peyer
CIK 1843594 · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
60
Lifetime Open-Market Net
$3.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics, Inc. (SNSE) Delisted | Director | 286,601 | $13.85 | $3.97M | $3.37M | 58 | 2026-06-01 |
Recent Filings · Page 3 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-14 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +17,500 | $77.9K | EDGAR |
| 2022-02-08 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +30,000 | $135.8K | EDGAR |
| 2022-01-31 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +15,000 | $63.8K | EDGAR |
| 2022-01-27 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +50,000 | $235.8K | EDGAR |
| 2022-01-25 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +47,410 | $228.5K | EDGAR |
| 2022-01-21 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +30,244 | $154.3K | EDGAR |
| 2022-01-20 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +10,000 | $50.8K | EDGAR |
| 2022-01-18 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +26,172 | $133.4K | EDGAR |
| 2022-01-13 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +20,047 | $104.2K | EDGAR |
| 2022-01-11 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Buy (P) | +10,000 | $52.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.